1. Menei
P
, MétellusP, LoiseauH, CapelleL, JacquetG, GuyotatJ
Biodegradable carmustine-impregnated wafers (Gliadel®): the French experience. Paper presented at the 8th Congress of the European Association of Neurooncology; September 12–14, 2008; Barcelona, Spain.
2. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme;McGirt;J Neurosurg,2009
3. La Rocca
R
, VitazTW, VillanuevaW, et al.
A phase 2 study of multi-modal therapy with surgery, carmustine (BCNU) wafer, radiation therapy (RT), and temozolomide (TMZ) in patients (pts) with newly diagnosed supratentorial malignant glioma (MG). Paper presented at: the 8th Congress of the European Association of Neurooncology; September 12–14, 2008; Barcelona, Spain.
4. Use of Gliadel (BCNU) wafer in surgical treatment of glioma: a 10-year institutional experience;Attenello;Ann Surg Oncol.,2008
5. Radical surgery in the management of low-grade and high-grade gliomas;Rostomily;Baillieres Clin Neurol.,1996